Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary R Cutter

Showing results (281-290 of 296) with videos related to

Pageof 30
Sort By:
Biorxiv : the Preprint Server for Biology|May 3, 2023
Neoadjuvant systemic oncolytic vesicular stomatitis virus is safe and may enhance long-term survivorship in dogs with naturally occurring osteosarcomaKelly M Makielski, Aaron L Sarver, Michael S Henson, et al.
Annals of Neurology|June 3, 2010
Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosisLauren S Talman, Esther R Bisker, David J Sackel, et al.
Physiological Genomics|July 14, 2025
Multidimensional biocircuitry of exercise adaptation: integrating in vivo and ex vivo phenomics with miRNA mappingJeremy S McAdam, Michael P Craig, Zachary A Graham, et al.
Pediatric Neurology|October 8, 2025
Neurodevelopmental Outcomes From the PREVeNT TrialSarah E O'Kelley, Jamie K Capal, Tarrant O McPherson, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2025
Multidimensional Modeling to Maximize Adaptations to eXercise: The M<sup>3</sup>AX Trial Rationale and Study DesignZachary A Graham, Matthew P Bubak, Christiana J Raymond-Pope, et al.
Neurology|May 30, 2014
Defining the clinical course of multiple sclerosis: the 2013 revisionsFred D Lublin, Stephen C Reingold, Jeffrey A Cohen, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|September 27, 2025
Multidimensional Modeling to Maximize Adaptations to eXercise: the M<sup>3</sup>AX trial rationale and study designZachary A Graham, Matthew P Bubak, Christiana J Raymond-Pope, et al.
Annals of Neurology|July 28, 2016
Long-term evolution of multiple sclerosis disability in the treatment era, Bruce A C Cree, Pierre-Antoine Gourraud, et al.
Nature Medicine|January 14, 2021
Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trialMichael J Fisher, Chie-Schin Shih, Steven D Rhodes, et al.
Neurology|June 12, 2026
Application of the 2024 McDonald Criteria in Individuals With Nonspecific Symptoms or Incidental Imaging Findings in a Multicenter StudyAlexandra Scharf, Jeffrey A Cohen, Ruth Ann Marrie, et al.
Pageof 30

Showing results (281-290 of 296) with videos related to

Sort By:
Pageof 30
Biorxiv : the Preprint Server for Biology|May 3, 2023
Neoadjuvant systemic oncolytic vesicular stomatitis virus is safe and may enhance long-term survivorship in dogs with naturally occurring osteosarcomaKelly M Makielski, Aaron L Sarver, Michael S Henson, et al.
Annals of Neurology|June 3, 2010
Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosisLauren S Talman, Esther R Bisker, David J Sackel, et al.
Physiological Genomics|July 14, 2025
Multidimensional biocircuitry of exercise adaptation: integrating in vivo and ex vivo phenomics with miRNA mappingJeremy S McAdam, Michael P Craig, Zachary A Graham, et al.
Pediatric Neurology|October 8, 2025
Neurodevelopmental Outcomes From the PREVeNT TrialSarah E O'Kelley, Jamie K Capal, Tarrant O McPherson, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2025
Multidimensional Modeling to Maximize Adaptations to eXercise: The M<sup>3</sup>AX Trial Rationale and Study DesignZachary A Graham, Matthew P Bubak, Christiana J Raymond-Pope, et al.
Neurology|May 30, 2014
Defining the clinical course of multiple sclerosis: the 2013 revisionsFred D Lublin, Stephen C Reingold, Jeffrey A Cohen, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|September 27, 2025
Multidimensional Modeling to Maximize Adaptations to eXercise: the M<sup>3</sup>AX trial rationale and study designZachary A Graham, Matthew P Bubak, Christiana J Raymond-Pope, et al.
Annals of Neurology|July 28, 2016
Long-term evolution of multiple sclerosis disability in the treatment era, Bruce A C Cree, Pierre-Antoine Gourraud, et al.
Nature Medicine|January 14, 2021
Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trialMichael J Fisher, Chie-Schin Shih, Steven D Rhodes, et al.
Neurology|June 12, 2026
Application of the 2024 McDonald Criteria in Individuals With Nonspecific Symptoms or Incidental Imaging Findings in a Multicenter StudyAlexandra Scharf, Jeffrey A Cohen, Ruth Ann Marrie, et al.
Pageof 30